RankAlpha logo
Back to Rankings

FTRE

FortreaB
Nasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
Quote time unavailable
View Chart
Current thesis
Raised FY2026 guidance, positive book-to-bill, large backlog, and improved adjusted EBITDA and adjusted EPS support a constructive execution case [#SEC-8K-2026-07-29].
Posture
Constructive
Lead driver
Sentiment
What changed
Sentiment remains the lead driver in the composite, 7D delta +11.4.
What can break
Backlog conversion, demand durability, margins, and cash-flow execution remain key monitoring points.
Momentum
35
Value
63
Sentiment
74
Setup hits (3d)
0 · Net Neutral
AI TargetsBase $18.53 · Bull $21.25 · Bear $14.80Analysis 2026-08-17; returns require an exact persisted reference.
Data freshness
Prices
Unavailable: Price unavailable
Fundamentals
As of 2026-08-17 • Vendor: Data Vendor v1
Scores
As of 2026-09-09 • Model: HYBRID_IC_RP
AI Memo
As of 2026-08-17 • Model: RankAlpha Sentiment Codex
Investment thesis
As of 2026-09-09

Grade is the composite factor band; factor scores use a 0–100 scale. Confidence describes evidence quality, not a probability of return. Score date: 2026-09-09. Definitions

Supporting evidence
What
Grade B · Constructive
Confidence Medium · Net Neutral
Target $21.25
Why
Momentum35 · Δ7d +8.1
Value63 · Δ7d -0.0
Sentiment74 · Δ7d +11.4
So what
Strength-led posture (Net Neutral). Favor watchlist adds and disciplined entries.

Confirming evidence

  • Sentiment remains the lead driver in the composite, 7D delta +11.4.

Contradictions & invalidation

  • Backlog conversion, demand durability, margins, and cash-flow execution remain key monitoring points.
  • Ongoing CFO leadership uncertainty may weigh on execution confidence.
  • Revenue remains below the prior-year quarter, CFO availability is uncertain, and recent open-market insider sales add confidence risk [#PR-EARNINGS-2026-08-08] [#SEC-FORM4-2026-08-07].

Catalyst clock

2026-07-29

Q2 execution and raised FY2026 guidance

Lead driver: Sentiment · See AI snapshot
Momentum
35
9% active weight
Current posture
7d trendImproving
Δ7d
+8.1
Δ21d
-50.4
Value
63
28% active weight
Current posture
7d trendFlat
Δ7d
-0.0
Δ21d
+2.1
Sentiment
74
62% active weight
Current posture
7d trendImproving
Δ7d
+11.4
Δ21d
+6.2
Why this grade

Composite grade B. Momentum 35.2 / Value 62.5 / Sentiment 74.5

Scenario snapshot

Scenario probability is memo-authored likelihood, not forecast certainty. Targets belong to the analysis dated 2026-08-17. Scenario method

B+
Bull case
25%
Probability
Target price
$21.25
Analysis reference price unavailable
Analysis 2026-08-17 · RankAlpha Sentiment Codex
Most likely
B
Base case
50%
Probability
Target price
$18.53
Analysis reference price unavailable
Analysis 2026-08-17 · RankAlpha Sentiment Codex
B-
Bear case
25%
Probability
Target price
$14.80
Analysis reference price unavailable
Analysis 2026-08-17 · RankAlpha Sentiment Codex
Fundamentals (TTM)
As of 2026-08-17
Market Cap
$1.72B
Beta
-
Shares Out
95.1M
P/E (TTM) · Derived
-1.7
P/S (TTM)
0.56
P/FCF (TTM)
6.47
Rev YoY
-4.5%
EPS YoY
-96.6%
Gross Margin
+16.4%
Op Margin
+1.0%
Net Debt
$941.4M
Current Ratio
0.96
As of 2026-09-09 • Updated nightlySource: Internal modelMethods & Data